Ho D - Search Results

1

Phase I trial of a 72-h continuous-infusion schedule of fazarabine.

Amato R, Ho D, Schmidt S, Krakoff IH, Raber M. Amato R, et al. Among authors: ho d. Cancer Chemother Pharmacol. 1992;30(4):321-4. doi: 10.1007/BF00686303. Cancer Chemother Pharmacol. 1992. PMID: 1379523 Clinical Trial.

2

Clinical pharmacology of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) following 72-hour infusion.

Ho DH, Brown N, Lin JR, Covington W, Newman RA, Raber M, Amato R, Schmidt S, Krakoff IH. Ho DH, et al. Drug Metab Dispos. 1991 May-Jun;19(3):643-7. Drug Metab Dispos. 1991. PMID: 1717216

3

Phase I trial of FK973: description of a delayed vascular leak syndrome.

Pazdur R, Ho DH, Daugherty K, Bradner WT, Krakoff IH, Raber MN. Pazdur R, et al. Among authors: ho dh. Invest New Drugs. 1991 Nov;9(4):377-82. doi: 10.1007/BF00183587. Invest New Drugs. 1991. PMID: 1804817 Clinical Trial.

4

Depletion of patients' plasma tryptophan using tryptophan side-chain oxidase columns.

Ho DH, Covington WP, Wallerstein RO, Hester JP, Lin JR, Brown NS, Newman RA, Krakoff IH, Freireich EJ. Ho DH, et al. Cancer Invest. 1993;11(3):252-7. doi: 10.3109/07357909309024849. Cancer Invest. 1993. PMID: 8485647

5

Clinical pharmacology of 11-acetyl-8-carbamoyloxymethyl-4-formyl-14-oxa-1,11-diazatetracyclo (7.4.1.0(2,7).0(10,12) tetradeca-2,4,6-trien-6,9-diyl diacetate (FK 973).

Ho DH, Pazdur R, Brown NS, Covington WP, Raber MN, Krakoff IH. Ho DH, et al. Anticancer Res. 1993 Mar-Apr;13(2):343-6. Anticancer Res. 1993. PMID: 8517646

6

Clinical pharmacology of combined oral uracil and ftorafur.

Ho DH, Covington WP, Pazdur R, Brown NS, Kuritani J, Newman RA, Raber MN, Krakoff IH. Ho DH, et al. Drug Metab Dispos. 1992 Nov-Dec;20(6):936-40. Drug Metab Dispos. 1992. PMID: 1362949 Clinical Trial.

7

Polyethylene glycol-L-asparaginase and L-asparaginase studies in rabbits.

Ho DH, Wang CY, Lin JR, Brown N, Newman RA, Krakoff IH. Ho DH, et al. Drug Metab Dispos. 1988 Jan-Feb;16(1):27-9. Drug Metab Dispos. 1988. PMID: 2894951

8

Clinical pharmacology of trimetrexate.

Ho DH, Covington WP, Legha SS, Newman RA, Krakoff IH. Ho DH, et al. Clin Pharmacol Ther. 1987 Sep;42(3):351-6. doi: 10.1038/clpt.1987.160. Clin Pharmacol Ther. 1987. PMID: 2957140

9

Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule.

Pazdur R, Lassere Y, Diaz-Canton E, Ho DH. Pazdur R, et al. Among authors: ho dh. Cancer Invest. 1998;16(3):145-51. doi: 10.3109/07357909809050028. Cancer Invest. 1998. PMID: 9541627 Clinical Trial.

10

Clinical pharmacology of polyethylene glycol-L-asparaginase.

Ho DH, Brown NS, Yen A, Holmes R, Keating M, Abuchowski A, Newman RA, Krakoff IH. Ho DH, et al. Drug Metab Dispos. 1986 May-Jun;14(3):349-52. Drug Metab Dispos. 1986. PMID: 2872037

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,377 results

Search Page

Filters